A VAN der SAR - JoVE Visualize

Showing results (21-30 of 22) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 22 results.

BMC Cancer|March 24, 2023

Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancerLotte G Zuur, Denise S Hoogenkamp, Esmée C A van der Sar, et al.

Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 22 results.

BMC Cancer|March 24, 2023

Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)Esmée C A van der Sar, Arthur J A T Braat, Jochem R N van der Voort-van Zyp, et al.

European Journal of Nuclear Medicine and Molecular Imaging|May 27, 2026

PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancerLotte G Zuur, Denise S Hoogenkamp, Esmée C A van der Sar, et al.

Pageof 3